▼ SELL
10b5-1 Plan
$ Value
$50K
Shares
1,657
Price
$30
Filed
Dec 3
Insider
Name
Matsuda Masaru
Title
See Remarks
CIK
0001798679
Roles
Officer
Transaction Details
Transaction Date
2025-12-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
150,641
Footnotes
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026. | Includes 822 shares acquired under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on November 30, 2025.
Filing Info
Matsuda Masaru's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | ARQT | ▼ | $165K |
| 2026-03-02 | ARQT | ▼ | $5K |
| 2026-03-02 | ARQT | ▼ | $51K |
| 2026-02-27 | ARQT | A | $0 |
| 2026-02-27 | ARQT | ▼ | $93K |
| 2026-02-27 | ARQT | A | $0 |
| 2026-02-02 | ARQT | ▼ | $204K |
| 2026-02-02 | ARQT | ▼ | $214K |
| 2026-02-02 | ARQT | ▼ | $489K |
| 2026-02-02 | ARQT | ▼ | $121K |
Other Insiders at ARQT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Leonard Keith R | — | $997K | 2026-03-02 |
|
Burnett Patrick
See Remarks
|
— | $505K | 2026-03-02 |
|
Matsuda Masaru
See Remarks
|
— | $1.3M | 2026-03-02 |
| Welgus Howard G. | — | $746K | 2026-04-01 |
|
Watanabe Todd
See Remarks
|
— | $1.4M | 2026-03-02 |
|
Edwards Larry Todd
See Remarks
|
— | $145K | 2026-03-02 |
|
Vairavan Latha
SVP Chief Financial Officer
|
— | $106K | 2026-03-02 |